BAX and brain ischemia: Our FBP9R, combined with anti-apoptotic siRNA targeting Bax involved in the intrinsic apoptosis pathway and administered intranasally, precisely localizes and delivers siBax to Fas-expressing infarcted regions in brain ischemia, resulting in a significant inhibition of ischemic-induced apoptosis.